P13K-MTORC1-S6K1 signaling pathway biomarkers predictive of anti-cancer responses
US11366100B2 · kind B2 · utility
0Cited by
2References
4Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | Feb 12, 2015 |
| Grant date | Jun 21, 2022 |
| Priority date | — |
| Expiry date | May 16, 2035 |
Classification
- Technology area (CPC G)Physics
- CPC primaryG01N2500/10
- WIPO fieldMeasurement
- WIPO sectorInstruments
Abstract
The present invention is based, in part, on the identification of novel FI.3K-mTORCI-S6K 1 signaling pathway biomarkers predictive of responsiveness to anti-cancer therapies.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.